These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25696150)

  • 1. Wake up call for Dutch cardiologists.
    Serruys PW; Ong AT
    Neth Heart J; 2003 Oct; 11(10):405-411. PubMed ID: 25696150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial.
    van Hout BA; Serruys PW; Lemos PA; van den Brand MJ; van Es GA; Lindeboom WK; Morice MC
    Heart; 2005 Apr; 91(4):507-12. PubMed ID: 15772214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary artery stents: a rapid systematic review and economic evaluation.
    Hill R; Bagust A; Bakhai A; Dickson R; Dündar Y; Haycox A; Mujica Mota R; Reaney A; Roberts D; Williamson P; Walley T
    Health Technol Assess; 2004 Sep; 8(35):iii-iv, 1-242. PubMed ID: 15361315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden.
    James SK; Stenestrand U; Lindbäck J; Carlsson J; Scherstén F; Nilsson T; Wallentin L; Lagerqvist B;
    N Engl J Med; 2009 May; 360(19):1933-45. PubMed ID: 19420363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-stent restenosis.
    Kim MS; Dean LS
    Cardiovasc Ther; 2011 Jun; 29(3):190-8. PubMed ID: 20406239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous coronary intervention with second-generation drug-eluting stent versus bare-metal stent: Systematic review and cost-benefit analysis.
    Poder TG; Erraji J; Coulibaly LP; Koffi K
    PLoS One; 2017; 12(5):e0177476. PubMed ID: 28498849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Potential impact of drug-eluting stents in Sicily: results from a multicenter survey and cost-benefit analysis of drug-eluting stents versus bare metal stents].
    Gulizia M; Martelli E; Tamburino C; Tolaro S; Frasheri A; Giambanco F; Grassi R; Fiscella A; Milazzo D
    Ital Heart J Suppl; 2004 Aug; 5(8):630-8. PubMed ID: 15554018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expert consensus (SBC/SBHCI) on the use of drug-eluting stents: recommendations of the Brazilian society of interventional cardiology/ Brazilian society of cardiology for the Brazilian public single healthcare system.
    Lima VC; Mattos LA; Caramori PR; Perin MA; Mangione JA; Machado BM; Coelho WM; Bueno RR
    Arq Bras Cardiol; 2006 Oct; 87(4):e162-7. PubMed ID: 17128305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analyses of drug eluting stents versus bare metal stents: a systematic review of the literature.
    Neyt M; Van Brabandt H; Devriese S; De Laet C
    Health Policy; 2009 Jul; 91(2):107-20. PubMed ID: 19135756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitäts Trial (BASKET): an 18-month analysis.
    Brunner-La Rocca HP; Kaiser C; Bernheim A; Zellweger MJ; Jeger R; Buser PT; Osswald S; Pfisterer M;
    Lancet; 2007 Nov; 370(9598):1552-9. PubMed ID: 17980734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of drug-eluting stents: a systematic review.
    Ligthart S; Vlemmix F; Dendukuri N; Brophy JM
    CMAJ; 2007 Jan; 176(2):199-205. PubMed ID: 17179219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential relative efficacy between drug-eluting stents in patients with bare metal and drug-eluting stent restenosis; evidence in support of drug resistance: insights from the ISAR-DESIRE and ISAR-DESIRE 2 trials.
    Byrne RA; Cassese S; Windisch T; King LA; Joner M; Tada T; Mehilli J; Pache J; Kastrati A
    EuroIntervention; 2013 Nov; 9(7):797-802. PubMed ID: 23687095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel Drug-Eluting Stents in Peripheral Arterial Disease: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2015; 15(20):1-62. PubMed ID: 26719778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes.
    Greenhalgh J; Hockenhull J; Rao N; Dundar Y; Dickson RC; Bagust A
    Cochrane Database Syst Rev; 2010 May; (5):CD004587. PubMed ID: 20464732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
    Ray GM; Nawarskas JJ; Frishman WH
    Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of drug-eluting stents: current best available evidence.
    Raja SG; Dreyfus GD
    J Card Surg; 2006; 21(6):605-12; discussion 613-4. PubMed ID: 17073969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
    J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.